December 13 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Friday that its CEO Ognyan Donev has acquired 1,000 shares in the company at a weighted average price of 3.45 levs ($1.96/1.76 euro) per share.
Sopharma's largest shareholder - Donev Investments Holding, which is controlled by Donev, also bought 1,000 shares at a price of 3.45 levs apiece, Sopharma said in a bourse filing.
At the same time, local company Telso sold 20,000 shares at a weighted average price of 3.43 levs,
At the end of September, both Donev and Telso held a stake of below 5% in Sopharma directly, according to the company's most recent interim financial statement.
Donev Investments Holding owned a 25.39% stake in Sopharma at the end of September.
Donev is also a major shareholder in Sopharma's second biggest shareholder - Telecomplect Invest, which controls 20.68% interest in Sopharma.
As at 14:00 CET on Friday, Sopharma shares traded at 3.45 levs, unchanged from their previous closing price on the Bulgarian Stock Exchange.
(1 euro = 1.95583 levs)